Reagentia en instrumenten voor immunologie, celbiologie en moleculaire biologie.
Inloggen
Wachtwoord vergeten?
Open een account
fr
en
es
de
it
pt
nl
0
0
Naar winkelmandje
Catalogus
Onderzoeksgebieden
Diagnostiek
Diensten op maat
CRO services
Technische middelen
Promoties
Contact
Reagentia en instrumenten voor immunologie, celbiologie en moleculaire biologie.
Resultaat van uw zoeken : 35 product gevonden
Verfijn uw zoekopdracht :
RUO
CE / IVD
Conjugate (1)
Unconjugated
9
Class (2)
Inhibitor/Antagonist/Agonist
24
Biochemicals
11
BRENG DE FILTERS AAN
INITIALISEREN
DEEL DEZE ZOEKOPDRACHT
GEKOPIEERD
10
20
50
100
200
500
Referentie
Beschrijving
Cond.
Price Bef. VAT
orb1710570-5mg
Anti-neurodegeneration agent 1
5mg
orb1710570-100mg
Anti-neurodegeneration agent 1
100mg
orb1710570-50mg
Anti-neurodegeneration agent 1
50mg
orb1708097-50mg
Neurodegenerative Disorder-Targeting Compound 1
50mg
orb1708097-5mg
Neurodegenerative Disorder-Targeting Compound 1
5mg
orb1708097-100mg
Neurodegenerative Disorder-Targeting Compound 1
100mg
T13486-100mg
Neurodegenerative Disorder-Targeting Compound 1 [1254698-39-9]
100mg
T13486-50mg
Neurodegenerative Disorder-Targeting Compound 1 [1254698-39-9]
50mg
T83527-50mg
(Rac)-Neurodegenerative Disorder-Targeting Compound 1 [1254699-12-1]
50mg
T83527-5mg
(Rac)-Neurodegenerative Disorder-Targeting Compound 1 [1254699-12-1]
5mg
orb1910676-250mg
COH1 is a ribonucleotide reductase (RR) inhibitor. COH1 can be used in research into cancer, mitochondrial diseases, and neurodegenerative diseases. [[20217-22-5]]
250mg
orb1910676-100mg
COH1 is a ribonucleotide reductase (RR) inhibitor. COH1 can be used in research into cancer, mitochondrial diseases, and neurodegenerative diseases. [[20217-22-5]]
100mg
orb1910646-1g
ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.
1g
orb1910646-250mg
ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.
250mg
orb1910646-100mg
ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.
100mg
orb1910676-1g
COH1 is a ribonucleotide reductase (RR) inhibitor. COH1 can be used in research into cancer, mitochondrial diseases, and neurodegenerative diseases. [[20217-22-5]]
1g
orb1910497-1g
Pifithrin-β (PFT β hydrobromide; Cyclic Pifithrin-α hydrobromide) is a potent inhibitor of p53 with an IC50 of 23 μM and is regarded as a lead compound for cancer and neurodegenerative disease therapy. [[60477-34-1]]
1g
orb1910497-100mg
Pifithrin-β (PFT β hydrobromide; Cyclic Pifithrin-α hydrobromide) is a potent inhibitor of p53 with an IC50 of 23 μM and is regarded as a lead compound for cancer and neurodegenerative disease therapy. [[60477-34-1]]
100mg
orb1910497-250mg
Pifithrin-β (PFT β hydrobromide; Cyclic Pifithrin-α hydrobromide) is a potent inhibitor of p53 with an IC50 of 23 μM and is regarded as a lead compound for cancer and neurodegenerative disease therapy. [[60477-34-1]]
250mg
HY-L086-30ul
Neurodegenerative Disease-related Compound Library
30ul
‹
›
